This 90-minute webinar will cover the basic principles of pharmacogenomics and pharmacogenetics and will discuss in detail the steps behind implementing a clinical pharmacotenomic testing service.
Why Should You Attend:
The FDA's Center for Drug Education and Research has relabeled many drugs recommending pharmacogenomic testing. In other cases, the FDA has issued "black box" warnings cautioning doctors that there are genetic variances that effect safety profile for drugs such as codeine and clopidogrel. These FDA mandates have driven the adoption of pharmacogenomic testing into clinical practice to date.
Pharmacogenomic laboratory tests are available for these drugs.Adverse events caused by these drugs may lead to medical malpractices should there be a failure to account for these variances.
Personalized medicine involves providing the right drug for the right patient at the right time. Drug dosing regimens for medications in routine clinical practice are established for the majority of individuals (wildtype). Unfortunately, individuals with genetic variances in genes that encode drug metabolizing or transport enzymes who are given standard dosages can result in poor drug efficacy or significant toxicity. Clinical pharmacogenetic testing is a means for personalizing medicine.
Areas Covered in the Seminar:
- Basic principles of pharmacogenomics and pharmacogenetics.
- Clinical benefits for pharmacogenomics testing.
- Costs and reimbursement for pharmacogenomics testing.
- Current drivers for pharmacogenomics testing.
- Available analytical testing technologies.
- Representative implementation of pharmacogenomics testing.
- Barriers to pharmacogenomics testing.